Glipizide
NDC 82868-035, Glipizide, tablet, extended release, from Northwind Health Company, LLC.
- Product NDC
- 82868-035
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206928
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82868-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE10 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82868-035-30 | 82868003530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-035-30) |
| 82868-035-90 | 82868003590 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-035-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0effd04d-172c-5d8c-e063-6294a90a93f4
Use it
Look up 82868-035 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82868-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82868-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.